Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Beximco Pharmaceuticals
Beximco Pharmaceuticals
Activities:
Manufacturing
Drug Delivery
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Ingredients
Beximco Pharma receives US FDA approval for antiarryhtmic drug Flecainide
Marks the company's eighth product approval for the US market
Ingredients
Beximco Pharma introduces first generic remdesivir for COVID-19
Beximco Pharma is donating remdesivir (Bemsivir) to the Bangladesh Government for supply only to Government hospitals
Personal Protection
Beximco Pharma donates PPE for the COVID-19 fight
Bangladeshi group has contributed $1.8 million to support this initiative
Finance
Mylan chooses Beximco for exclusive antibody distribution in Bangladesh
Beximco Pharma has received the exclusive rights to launch Netherlands-based Mylan’s portfolio of key monoclonal antibodies in its headquarters of Bangladesh
Manufacturing
Beximco Pharma: The Bangladeshi company connecting with the US
COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market
Regulatory
Beximco receives FDA approval for generic allergy drug
The nod for Bangladesh-based company is for the antihistamine drug, Cyproheptadine Hydrochloride, a generic equivalent of Periactin tablets form Merck
Regulatory
Beximco Pharma gets eight ANDAs from Sandoz
Deal with Novartis' division to boost Beximco's export sales to the US
Subscribe now